{"created":"2023-06-20T16:47:51.624266+00:00","id":19630,"links":{},"metadata":{"_buckets":{"deposit":"b08e7301-b6e4-483d-a48a-bfbf5dbb4ca6"},"_deposit":{"created_by":3,"id":"19630","owners":[3],"pid":{"revision_id":0,"type":"depid","value":"19630"},"status":"published"},"_oai":{"id":"oai:kindai.repo.nii.ac.jp:00019630","sets":["14:2529:2619:4395"]},"author_link":["33342"],"item_7_alternative_title_3":{"attribute_name":"その他（別言語等）のタイトル","attribute_value_mlt":[{"subitem_alternative_title":"T790M陽性EGFR-TKI耐性肺癌細胞株における第三世代EGFR-TKIとSrc阻害薬ダサチニブの併用効果の検討"}]},"item_7_biblio_info_21":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2018-03-20","bibliographicIssueDateType":"Issued"},"bibliographicPageEnd":"19","bibliographicPageStart":"1","bibliographic_titles":[{"bibliographic_title":"博士学位論文/本文(平成29年度授与)"}]}]},"item_7_description_36":{"attribute_name":"内容記述","attribute_value_mlt":[{"subitem_description":"学位の種類：医学　　学位授与年月日：平成30年3月20日　　主査：西尾　和人 教授　　報告番号：甲第1357号　　学内授与番号：医第1248号\nSatomi Watanabe, Takeshi Yoshida, Hisato Kawakami, Naoki Takegawa, Junko Tanizaki, Hidetoshi Hayashi, Masayuki Takeda, Kimio Yonesaka, Junji Tsurutani, and Kazuhiko Nakagawa Molecular Cancer Therapeutics, November 2017 Volume 16, Issue 11,  DOI: 10.1158/1535-7163.MCT-17-0351　　掲載","subitem_description_type":"Other"}]},"item_7_description_41":{"attribute_name":"フォーマット","attribute_value_mlt":[{"subitem_description":"application/pdf","subitem_description_type":"Other"}]},"item_7_publisher_14":{"attribute_name":"出版者 名前","attribute_value_mlt":[{"subitem_publisher":"近畿大学"}]},"item_7_text_8":{"attribute_name":"著者 所属","attribute_value_mlt":[{"subitem_text_value":"近畿大学"}]},"item_7_text_9":{"attribute_name":"著者所属(翻訳)","attribute_value_mlt":[{"subitem_text_value":"Kindai University"}]},"item_7_version_type_12":{"attribute_name":"版","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"open access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_abf2"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"渡邉, 諭美"},{"creatorName":"ワタナベ, サトミ","creatorNameLang":"ja-Kana"}],"nameIdentifiers":[{}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2018-11-02"}],"displaytype":"detail","filename":"Thesis_Summary Me1248-20180320-0001.pdf","filesize":[{"value":"6.9 MB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"Thesis_Summary Me1248-20180320-0001.pdf","url":"https://kindai.repo.nii.ac.jp/record/19630/files/Thesis_Summary Me1248-20180320-0001.pdf"},"version_id":"6596d923-1713-4118-b069-3a1fe750686e"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"doctoral thesis","resourceuri":"http://purl.org/coar/resource_type/c_db06"}]},"item_title":"T790M-selective EGFR-TKI combined with dasatinib as an optimal strategy for overcoming EGFR-TKI resistance in T790M-positive non-small cell lung cancer","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"T790M-selective EGFR-TKI combined with dasatinib as an optimal strategy for overcoming EGFR-TKI resistance in T790M-positive non-small cell lung cancer"}]},"item_type_id":"7","owner":"3","path":["4395"],"pubdate":{"attribute_name":"公開日","attribute_value":"2018-11-06"},"publish_date":"2018-11-06","publish_status":"0","recid":"19630","relation_version_is_last":true,"title":["T790M-selective EGFR-TKI combined with dasatinib as an optimal strategy for overcoming EGFR-TKI resistance in T790M-positive non-small cell lung cancer"],"weko_creator_id":"3","weko_shared_id":3},"updated":"2023-06-20T21:37:10.976413+00:00"}